Loading...

Home
ETF
LABT

LABT

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

LABT News

Lakewood-Amedex Advances Nu-3 Towards Phase 2 Clinical Trial

6d agoPRnewswire

Lakewood-Amedex Partners with PERI to Advance Nu-3 Clinical Trial

May 12 2026PRnewswire

Lakewood-Amedex Announces Positive AMR Data for Nu-3 Antimicrobial

May 01 2026Newsfilter

Lakewood-Amedex Appoints New Board Member to Strengthen Governance

Apr 28 2026PRnewswire

Lakewood-Amedex Appoints New Board Member to Strengthen Governance

Apr 28 2026Newsfilter

Lakewood-Amedex Completes Direct Listing on Nasdaq

Apr 27 2026renaissancecapital

Lakewood-Amedex Biotherapeutics Listing Accelerates Development of Nu-3

Apr 24 2026stocktwits

Lakewood-Amedex Biotherapeutics Goes Public on Nasdaq

Apr 24 2026NASDAQ.COM

Lakewood-Amedex Biotherapeutics Begins Trading on Nasdaq

Apr 23 2026Newsfilter

Lakewood-Amedex Biotherapeutics Begins Trading on Nasdaq Under LABT

Apr 23 2026PRnewswire